
Bortenat 2mg Injection
Marketer
Natco Pharma Ltd
Salt Composition
Bortezomib (2mg)
Overview Bortenat 2mg Injection
Myeloma and mantle cell lymphoma are treated with the injectable medication, Bortezomib 2mg. Its mechanism of action involves inhibiting or retarding cancerous cell proliferation. Administration is via injection by a healthcare professional; dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; improper use or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include fatigue, nausea, vomiting, and anorexia. Increased daily fluid intake is often recommended. Operating machinery or driving should be avoided due to potential drowsiness and dizziness. This medication can reduce blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests to monitor blood cell counts, along with heart, liver, and uric acid levels are essential. Prior to commencing Bortezomib 2mg, discuss any pre-existing liver, kidney, heart conditions, or bleeding disorders with your physician. Report any cognitive symptoms, such as memory impairment or difficulty concentrating. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners throughout treatment.
Uses of Bortenat 2mg Injection
Myeloma and mantle cell lymphoma
Major Benefits of Bortenat 2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Bortenat 2mg Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Bortenat 2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Bortenat 2mg Injection works:
Bortenat 2mg Injection is an antineoplastic agent. Its mechanism of action involves inhibiting the degradation of intracellular proteins. This protein accumulation within cancerous cells ultimately triggers their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Bortenat 2mg Injection and alcohol may result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Bortenat 2mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Bortenat 2mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Bortenat 2mg Injection may induce adverse reactions impacting driving capabilities. These potential effects include fatigue, vertigo, syncope, or visual disturbances, all of which could impair driving ability.
KidneyCAUTION
For individuals with severely impaired kidney function, administering Bortenat 2mg Injection requires careful consideration. Dosage modification of Bortenat 2mg Injection might be necessary. A physician's consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Bortenat 2mg Injection. A modified dosage of Bortenat 2mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Bortenat 2mg Injection :
Omitting a scheduled dose of Bortenat 2mg Injection necessitates contacting your physician.
Facts to Know About Bortenat 2mg Injection
| Label | Value |
|---|---|
| Chemical Category | Phenylalanine-based Compounds |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
